GILEAD SCIENCES, INC. — Director's Dealing 2018

May 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-05-08

Reporting Person: McHutchison John G (Chief Scientific Off/HeadR&D)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-08	Non-qualified Stock Option (Right to Buy)	$65.22	A	79710	Acquired	2028-05-08	Common Stock (79710)	Direct

Footnotes

F1: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested